Search results for "PEPTIDE"

showing 10 items of 4589 documents

Cholera Toxin Subunit B for Sensitive and Rapid Determination of Exosomes by Gel Filtration.

2020

We developed a sensitive fluorescence-based assay for determination of exosome concentration. In our assay, Cholera toxin subunit B (CTB) conjugated to a fluorescence probe and a gel filtration technique (size-exclusion chromatography) are used. Exosomal membranes are particularly enriched in raft-forming lipids (cholesterol, sphingolipids, and saturated phospholipids) and in GM1 ganglioside. CTB binds specifically and with high affinity to exosomal GM1 ganglioside residing in rafts only, and it has long been the probe of choice for membrane rafts. The CTB-gel filtration assay allows for detection of as little as 3 × 108 isolated exosomes/mL in a standard fluorometer, which has a sensitivit…

0301 basic medicineliposomesgel chromatographySize-exclusion chromatographyFiltration and Separationexosomesmedicine.disease_causelcsh:Chemical technologyExosomeGel permeation chromatography03 medical and health sciences0302 clinical medicineFluorometermedicineChemical Engineering (miscellaneous)lcsh:TP1-1185lcsh:Chemical engineeringcholera toxin subunit BQuantitation RangeLiposomeChromatographyChemistryGM1 ganglioside; cholera toxin subunit B; cholesterol; exosomes; gel chromatography; liposomesProcess Chemistry and TechnologyCommunicationCholera toxinlcsh:TP155-156cholesterol030104 developmental biologyMembrane030220 oncology & carcinogenesislipids (amino acids peptides and proteins)GM1 gangliosideMembranes
researchProduct

The swinholide biosynthesis gene cluster from a terrestrial cyanobacterium, Nostoc sp. strain UHCC 0450

2017

ABSTRACT Swinholides are 42-carbon ring polyketides with a 2-fold axis of symmetry. They are potent cytotoxins that disrupt the actin cytoskeleton. Swinholides were discovered from the marine sponge Theonella sp. and were long suspected to be produced by symbiotic bacteria. Misakinolide, a structural variant of swinholide, was recently demonstrated to be the product of a symbiotic heterotrophic proteobacterium. Here, we report the production of swinholide A by an axenic strain of the terrestrial cyanobacterium Nostoc sp. strain UHCC 0450. We located the 85-kb trans -AT polyketide synthase (PKS) swinholide biosynthesis gene cluster from a draft genome of Nostoc sp. UHCC 0450. The swinholide …

0301 basic medicinemarine environmentterrestrial environmentDIVERSITYcyanobacteria01 natural sciencesApplied Microbiology and BiotechnologyBiochemistryTrans-AT PKSMARINE CYANOBACTERIAGene clusterEnvironmental MicrobiologyskeletonSPONGE THEONELLA-SWINHOEISpotlightAxenicNostocgene transfertoxinSwinholide1183 Plant biology microbiology virologyPhylogenychemistry.chemical_classificationEcologybiologyAnabaena sp.ChemistryAnabaenaHorizontal gene transferKetonesbacteriumenzyme activityphylogeneticsINSIGHTSBiochemistryMultigene Familyhorizontal gene transferscytophycinScandium compoundspolyketidesBiotechnologyNostoctrans-AT PKSScytophycinNONRIBOSOMAL PEPTIDEBiosynthesisCyanobacteriaswinholideCYTOTOXIC DIMERIC MACROLIDES03 medical and health sciencesPolyketideBacterial ProteinsNonribosomal peptidecyanobacteriumPolyketide synthaseProteobacteriaCONGENERSCandidatus Entotheonellabovine spongiform encephalopathygeneNostoc sp.Bacteriacatalysis010405 organic chemistryProteinsSequence Analysis DNAbiology.organism_classificationActin cytoskeletonAnabaenaEVOLUTION"Candidatus Entotheonella"0104 chemical sciencesenzymeNATURAL-PRODUCT DISCOVERY030104 developmental biologyGenesPolyketidesbiology.proteingene expressionbacteria“Candidatus Entotheonella”Theonella sp.Marine ToxinsPolyketide SynthasesFood Sciencecatalyst
researchProduct

A Two-Component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance

2020

AbstractThe glycopeptide A40926, produced by the actinomycete Nonomuraea gerenzanensis, is the precursor of dalbavancin, a second-generation glycopeptide antibiotic approved for clinical use in the USA and Europe in 2014 and 2015, respectively. The final product of the biosynthetic pathway is an O-acetylated form of A40926 (acA40926). Glycopeptide biosynthesis in N. gerenzanensis is dependent upon the dbv gene cluster that encodes, in addition to the two essential positive regulators Dbv3 and Dbv4, the putative members of a two-component signal transduction system, specifically the response regulator Dbv6 and the sensor kinase Dbv22. The aim of this work was to assign a role to these two ge…

0301 basic medicinemedicine.drug_class030106 microbiologylcsh:MedicineGlycopeptide antibioticIndustrial microbiologyArticle03 medical and health sciencesBacterial ProteinsTranscription (biology)Genes RegulatorGene clustermedicinelcsh:ScienceGeneRegulator geneRegulation of gene expressionMultidisciplinaryAntimicrobialsChemistrylcsh:RGene Expression Regulation BacterialGlycopeptideAnti-Bacterial AgentsBiosynthetic PathwaysCell biologyActinobacteriaResponse regulator030104 developmental biologyMultigene FamilyTwo component regulatory system glycopeptide A40926 actinomycete Nonomuraea gerenzanensislcsh:QTeicoplaninMicrobial geneticsScientific Reports
researchProduct

Unexpected Bacterial Origin of the Antibiotic Icosalide: Two-Tailed Depsipeptide Assembly in Multifarious Burkholderia Symbionts.

2018

Icosalide is an unusual two-tailed lipocyclopeptide antibiotic that was originally isolated from a fungal culture. Yet, its biosynthesis and ecological function have remained enigmatic. By genome mining and metabolic profiling of a bacterial endosymbiont ( Burkholderia gladioli) of the pest beetle Lagria villosa, we unveiled a bacterial origin of icosalide. Functional analysis of the biosynthetic gene locus revealed an unprecedented nonribosomal peptide synthetase (NRPS) that incorporates two β-hydroxy acids by means of two starter condensation domains in different modules. This unusual assembly line, which may inspire new synthetic biology approaches, is widespread among many symbiotic Bur…

0301 basic medicinemedicine.drug_classBurkholderia030106 microbiologyAntibioticsBiochemistryGenomePeptides Cyclic03 medical and health sciencesGene clustermedicineAnimalsPeptide SynthasesSymbiosisGeneticsDepsipeptidebiologyPseudomonasGeneral Medicinebiology.organism_classificationAnti-Bacterial AgentsColeoptera030104 developmental biologyBurkholderiaGenes BacterialMolecular MedicineIdentification (biology)ACS chemical biology
researchProduct

The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties.

2020

The emergence of superbugs developing resistance to antibiotics and the resurgence of microbial infections have led scientists to start an antimicrobial arms race. In this context, we have previously identified an active RiPP, the Ruminococcin C1, naturally produced by Ruminococcus gnavus E1, a symbiont of the healthy human intestinal microbiota. This RiPP, subclassified as a sactipeptide, requires the host digestive system to become active against pathogenic Clostridia and multidrug-resistant strains. Here, we report its unique compact structure on the basis of four intramolecular thioether bridges introduced post-translationally by a specific radical-SAM sactisynthase. This structure con…

0301 basic medicinemedicine.drug_class[CHIM.THER] Chemical Sciences/Medicinal ChemistryAntibioticsgut microbiomeContext (language use)Peptide[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciencesMicrobiologyClostridia03 medical and health sciencesRuminococcus gnavusantibioticmedicineRiPPHumansIntestinal Mucosa[SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitologychemistry.chemical_classificationRadical SAM enzymeClostridialesMultidisciplinarybiologyRiPPs Ruminococcin C sactipeptide gut microbiome antibiotic[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyBacterial InfectionsBiological Sciencesbiology.organism_classificationAntimicrobialIntestinal epithelium[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology0104 chemical sciences3. Good healthsactipeptideAnti-Bacterial AgentsRuminococcus gnavusRiPPs030104 developmental biology[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologychemistryRuminococcin CPeptidesBacteriaProceedings of the National Academy of Sciences of the United States of America
researchProduct

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway

2017

The angiopoietin-like 4 (ANGPTL4) protein belongs to a superfamily of secreted proteins structurally related to factors modulating angiogenesis known as angiopoietins. At first, ANGPTL4 has been identified as an adipokine exclusively involved in lipid metabolism, because of its prevalent expression in liver and adipose tissue. This protein regulates lipid metabolism by inhibiting lipoprotein lipase (LPL) activity and stimulating lipolysis of white adipose tissue (WAT), resulting in increased levels of plasma triglycerides (TG) and fatty acids. Subsequently, ANGPTL4 has been shown to be involved in several nonmetabolic and metabolic conditions, both physiological and pathological, including …

0301 basic medicinemedicine.medical_specialtyAdipose tissueAdipokinePeroxisome proliferator-activated receptorWhite adipose tissueReview ArticleBiologyPPARANGPTL4; PPAR; Cancer03 medical and health sciencesANGPTL4ANGPTL4Internal medicineDrug DiscoverymedicineLipolysisPharmacology (medical)lcsh:QH301-705.5Cancerchemistry.chemical_classificationLipoprotein lipaseLipid metabolism030104 developmental biologyEndocrinologychemistrylcsh:Biology (General)lipids (amino acids peptides and proteins)metabolism
researchProduct

Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders

2017

BACKGROUND AND OBJECTIVE Eating Disorder (ED) is characterized by persistently and severely disturbed eating behaviours. They arise from a combination of long-standing behavioural, emotional, psychological, interpersonal, and social factors and result in insufficient nutrient ingestion and/or adsorption. The three main EDs are: anorexia nervosa, bulimia nervosa, and binge eating disorder. We review the role of peripheral endocannabinoids in eating behaviour. DISCUSSION The neuronal pathways involved in feeding behaviours are closely related to catecholaminergic, serotoninergic and peptidergic systems. Accordingly, feeding is promoted by serotonin, dopamine, and prostaglandin and inhibited b…

0301 basic medicinemedicine.medical_specialtyCannabinoid receptorEndocrinology Diabetes and Metabolismmedicine.medical_treatmentNutritional StatusFeeding and Eating Disorders03 medical and health sciencesIslets of LangerhansReceptor Cannabinoid CB1Binge-eating disorderInternal medicinemedicineImmunology and AllergyAnimalsHumansOpioid peptideMuscle Skeletal030109 nutrition & dieteticsBulimia nervosabusiness.industrydigestive oral and skin physiologyBody WeightBrainFeeding Behaviormedicine.diseaseEndocannabinoid systemEating disordersEndocrinologyAdipose TissueLiverAnorexia nervosa (differential diagnoses)CannabinoidbusinessEnergy MetabolismEndocannabinoidsSignal Transduction
researchProduct

Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors.

2021

Genetic deletion of cannabinoid CB1 receptors or diacylglycerol lipase alpha (DAGLa), the main enzyme involved in the synthesis of the endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG), produced profound phenotypes in animal models of depression-related behaviors. Furthermore, clinical studies have shown that antagonists of CB1 can increase the incidence and severity of major depressive episodes. However, the underlying pathomechanisms are largely unknown. In this study, we have focused on the possible involvement of astrocytes. Using the highly sensitive RNAscope technology, we show for the first time that a subpopulation of astrocytes in the adult mouse brain expresses Dagla, albeit at …

0301 basic medicinemedicine.medical_specialtyCannabinoid receptormedicine.medical_treatment2-Arachidonoylglycerol610 Medicine & healthBiology03 medical and health sciencesCellular and Molecular Neurosciencechemistry.chemical_compoundMice0302 clinical medicineReceptor Cannabinoid CB1Internal medicineTripartite synapseLipidomicsmedicineAnimalsReceptorMice KnockoutDepressive Disorder MajorEndocannabinoid system3. Good healthLipoprotein Lipase030104 developmental biologyEndocrinologyNeurologychemistryAstrocytes570 Life sciences; biologylipids (amino acids peptides and proteins)Arachidonic acidFemaleCannabinoid030217 neurology & neurosurgeryEndocannabinoidsGliaREFERENCES
researchProduct

Chronic hyponatremia in a patient with renal salt wasting and without cerebral disease: relationship between RSW, risk of fractures and cognitive imp…

2018

Renal salt wasting syndrome (RSW) is defined as a renal loss of sodium leading to hyponatremia and a decrease in extracellular fluid volume (ECV). Differentiation of this disorder from the syndrome of inappropriate antidiuretic hormone secretion (SIADH), a common cause of hyponatremia, can be difficult because both can present with hyponatremia and concentrated urine with natriuresis. Our clinical case about a 78-year-old woman with a recent fracture of the right femur not only confirms that this syndrome can occur in patients without intracranial pathologies (CT documented), but depicts how the hyponatremia caused by RSW can show a chronic, oscillating course. This is an interesting point …

0301 basic medicinemedicine.medical_specialtyChronic hyponatremiaNatriuresis03 medical and health sciences0302 clinical medicineCognitionInternal medicineExtracellular fluidCerebral salt wasting syndromeInternal MedicineMedicineHumansWasting SyndromeRenal Insufficiency ChronicAgedbusiness.industryWasting SyndromeRenal salt wasting syndromeSodiumSIADHfood and beveragesnutritional and metabolic diseasesCerebral salt-wasting syndromemedicine.diseaseChronic hyponatremia030104 developmental biologySyndrome of inappropriate antidiuretic hormone secretionEmergency MedicineCardiologyFemaleDifferential diagnosisbusinessHyponatremia030217 neurology & neurosurgeryNatriuretic peptideHumanHyponatremia
researchProduct

Expert opinion on the metabolic complications of mTOR inhibitors

2018

Abstract Using mTOR inhibitors (mTORi) as anticancer drugs led to hyperglycemia (12–50%) and hyperlipidemia (7–73%) in phase-III trials. These high rates require adapted treatment in cancer patients. Before initiating mTORi treatment, lipid profile screening should be systematic, with fasting glucose assay in non-diabetic patients and HbA1C in diabetic patients. After initiation, lipid profile monitoring should be systematic, with fasting glucose assay in non-diabetic patients, every 2 weeks for the first month and then monthly. The HbA1C target is ≤ 8%, before and after treatment initiation in known diabetic patients and in case of onset of diabetes under mTORi. LDL-cholesterol targets sho…

0301 basic medicinemedicine.medical_specialtyConsensusEndocrinology Diabetes and MetabolismAtorvastatinAntineoplastic Agents03 medical and health sciences0302 clinical medicineEndocrinologyMetabolic DiseasesNeoplasmsInternal medicineDiabetes mellitusHyperlipidemiamedicineHumansDyslipidemiasFenofibratemedicine.diagnostic_testbusiness.industryTOR Serine-Threonine KinasesHypertriglyceridemianutritional and metabolic diseasesGeneral Medicinemedicine.diseaseHypoglycemia030104 developmental biologySimvastatin030220 oncology & carcinogenesislipids (amino acids peptides and proteins)Lipid profilebusinessPravastatinmedicine.drugAnnales d'Endocrinologie
researchProduct